Streetbeat News

Stock Prices

MURA

Mural Oncology (NASDAQ:MURA) reported a Q2 2024 GAAP EPS of $(1.86), an improvement from $(3.01) per share in the same period last year, representing a 38.21% increase.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:21 am

TRDA

Entrada Therapeutics has announced that it has $470 million in cash, cash equivalents, and marketable securities as of June 30, which is expected to sustain the company’s operations until 2027.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:20 am

SNDL

SNDL has agreed to purchase the remaining 34.8% minority interest in Nova Cannabis for C$1.75 per share, totaling approximately C$40 million. This represents a 41.2% premium to the 20-day VWAP of Nova Shares on the Toronto Stock Exchange as of August 12, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:19 am

JSPR

Jasper Therapeutics (NASDAQ:JSPR) reported a Q2 2024 GAAP EPS of $(0.97), beating the analyst estimate of $(1.08) by 10.19%. This represents a 34.01% improvement over the same period last year. The company has $106.8M in cash.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:17 am

PSFE

Paysafe shares are trading higher after the company reported better-than-expected Q2 financial results and raised its guidance.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:17 am

POAI

Predictive Oncology has expanded the applications of its AI platform to address patient heterogeneity, de-risk drug discovery, and accelerate pipeline development. The platform supports biomarker discovery, clinical trial optimization, and target validation, increasing the Probability of Technical Success.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:16 am

SRAD

Sportradar Group shares are trading higher following a Q2 revenue beat and increased FY24 guidance.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:16 am

PRAX

Praxis Precision Medicine (NASDAQ:PRAX) reported Q2 2024 GAAP EPS of $(1.74), beating the estimate of $(2.31). However, sales of $357,000 missed the $870,000 estimate and decreased by 54.29% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:14 am

CCLD

CareCloud expects to further improve profitability and reduce its credit facility balance to zero in the coming months.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 11:14 am

BIDU

GOOG

MBLY

TSLA

Gary Black, Managing Partner at The Future Fund, expressed skepticism about Tesla's monopoly in the unsupervised L4/L5 autonomy market, highlighting competition from Baidu, Mobileye, and Alphabet's Waymo. Black believes these companies will achieve and receive approval for unsupervised autonomy around the same time as Tesla. He also noted the increasing segmentation between consumer and industrial-strength autonomous vehicles and questioned the evidence supporting Tesla's Full Self-Driving capability.

Portfolio Pulse from Benzinga Neuro

August 13, 2024 | 11:09 am